TMC Life Sciences Berhad Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended November 30, 2013
For the six months ended November 30, 2013, the company's revenue was MYR 41,807,000 against MYR 33,919,000 a year ago. Profit from operations was MYR 5,824,000 against MYR 4,717,000 a year ago. Interest income was MYR 374,000 against MYR 152,000 a year ago. Profit before tax was MYR 2,197,000 against profit before tax of MYR 975,000 a year ago. Profit from continuing operations was MYR 2,033,000 against profit from continuing operations of MYR 993,000 a year ago. Profit after taxation was MYR 2,033,000 against MYR 7,324,000 a year ago. Profit attributable to owners of the parent was MYR 2,033,000 against MYR 7,324,000 a year ago. Diluted earnings per ordinary share attributable to the owners of the parent were 0.17 sen against 0.63 a year ago. Net cash flows from operating activities was MYR 7,382,000 against MYR 4,072,000 a year ago.